Health
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas – ABC News
AstraZeneca and Oxford University’s potential COVID-19 vaccine produces a strong immune response in those aged over 70.
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the…
Continue Reading
-
General13 hours agoWA government rolls out suite of housing assistance ahead of state budget
-
Noosa News24 hours agoComing Soon: The Malibu Barbie Cafe Is Popping Up in Australia for the First Time, Complete with a Cocktail-Slinging Ken-Themed Bar
-
Business19 hours agoHow many Magnificent 7 stocks should I own?
-
Noosa News14 hours agoPolice investigate fire at Borrodell Estate winery restaurant near Orange